Press Room

Cancer Advocates Applaud the Senate’s Passage of Biomarker Testing Legislation, Ensuring Illinoisans Have Better Access to Personalized Care. 

NASHVILLE, Tenn. – On Tuesday, April 7, Senate Bill 0435 to expand coverage of biomarker testing in Tennessee overcame a significant hurdle, passing the Senate Commerce and Labor Committee.

NASHVILLE, Tenn. – On Monday, March 30, the Tennessee House unanimously passed House Bill 0484 that would expand coverage of biomarker testing for patients facing a variety of diseases includin

Cancer survivors and caregivers urge lawmakers to support legislation that will increase access to precision medicine through biomarker testing.

Earlier today, a coalition of patient advocates, legislative champions, public health leaders and concerned cancer survivors, led by the American Cancer Society Cancer Action Network (ACS CAN), came together to applaud the Senate and call on Governor Hochul and Assembly leadership to join the Senate in preserving Medicaid enrollees’ access to biomarker testing.

Doz

JACKSON, Miss. –  Cancer advocates are celebrating after Gov.

The one-house budget proposals revealed a clear divide in the Legislature’s approach to the equitable treatment of disease. The New York State Senate flatly rejected the governor’s proposal to roll back Medicaid coverage criteria for biomarker testing, heeding the calls of cancer survivors, patient advocates and public health organizations, like the American Cancer Society Cancer Action Network (ACS CAN). The Assembly took a more mixed approach accepting parts of the Governor’s proposed language while rejecting others.  

Earlier today, cancer survivors, medical professionals and patient advocates from across Delaware convened in Dover at Legislative Hall as a part of ‘Delaware Advocacy Day.’ The main focus of Advocacy Day, which was hosted by the American Cancer Society Cancer Action Network (ACS CAN) and the Alzheimer’s Association (ALZ), was for volunteers to connect directly with legislators and ask for their support of Senate Bill 120, a bipartisan proposal to improve Delawareans’ access to biomarker testing.

JACKSON, Miss. –  The Mississippi Senate passed “Jill’s Law” House Bill 565 Wednesday, paving the way for increased access to biomarker testing for Mississippians with state-regulated he